Finance

EU leaders to agree on top jobs, strategic agenda with focus on defence By Reuters

By Jan Strupczewski and Andrew Gray BRUSSELS (Reuters) - European Union leaders are to agree on Thursday on the strategic course for...

Your Apple Watch or Fitbit may be a breeding ground for E. coli and staph bacteria. Here’s how to clean your fitness tracker

Your fitness tracker might be carrying a dirty little secret, and it’s not how many steps you take. Many TikTok users have taken...

government bonds: Gilts to shine brighter from tomorrow

Mumbai: From Friday, a new era of global interconnectedness begins for the Indian sovereign debt market with government bonds' inclusion in an international...

Chewy buys back shares at discount, aims for capital efficiency By Investing.com

PLANTATION, Fla. - Chewy, Inc. (NYSE: NYSE:), a leading online retailer for pet products, has entered into an agreement to repurchase 17,550,000 shares...

US appeals court voids SEC rollback of proxy voting advice rule By Reuters

(Reuters) - A federal appeals court on Wednesday struck down part of the U.S. Securities and Exchange Commission's 2022 rescission of rules...

METALLA ANNOUNCES VOTING RESULTS FROM ANNUAL GENERAL MEETING By Investing.com

TSXV: MTANYSE AMERICAN: MTA VANCOUVER, BC, June 26, 2024 /PRNewswire/ - Metalla Royalty & Streaming Ltd. ("Metalla" or the "Company") (NYSE American: MTA) (TSXV:...

Ault Alliance buys Gresham Worldwide shares, total spend $1.3k By Investing.com

In a recent transaction, Ault Alliance, Inc. has increased its investment in Gresham Worldwide, Inc. (OTC:GIGA), an electronics and electrical measurement instruments manufacturer....

EPKINLY ® (epcoritamab-bysp) Approved by U.S. FDA for Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL) By Investing.com

Company Announcement Approval based on results from Phase 1/2 EPCORE ® NHL-1 study, which demonstrated durable, clinically meaningful treatment responses in patients with...

Nxera Pharma Receives US$10 Million from AbbVie as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone By Investing.com

Tokyo, Japan and Cambridge, UK, 27 June 2024 - Nxera Pharma Co. Ltd (Nxera; TSE 4565), announces that it has reached an important...
1...5,7885,7895,790...6,526Page 5,789 of 6,526

Latest articles

spot_imgspot_img